Zhang, B., Wang, L., Zhang, Q., Yan, Y., Jiang, H., Hu, R., . . . Lin, N. (2019). The Ibr‐7 derivative of ibrutinib exhibits enhanced cytotoxicity against non‐small cell lung cancer cells via targeting of mTORC1/S6 signaling. Mol Oncol.
Chicago Style CitationZhang, Bo, et al. "The Ibr‐7 Derivative of Ibrutinib Exhibits Enhanced Cytotoxicity against Non‐small Cell Lung Cancer Cells Via Targeting of MTORC1/S6 Signaling." Mol Oncol 2019.
MLA CitationZhang, Bo, et al. "The Ibr‐7 Derivative of Ibrutinib Exhibits Enhanced Cytotoxicity against Non‐small Cell Lung Cancer Cells Via Targeting of MTORC1/S6 Signaling." Mol Oncol 2019.
Warning: These citations may not always be 100% accurate.